Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice

Sarah J. Jefferson, View ORCID ProfileIan Gregg, View ORCID ProfileMark Dibbs, View ORCID ProfileClara Liao, Hao Wu, View ORCID ProfilePasha A. Davoudian, View ORCID ProfileJeffrey S. Sprouse, View ORCID ProfileAlexander M. Sherwood, View ORCID ProfileAlfred P. Kaye, View ORCID ProfileChristopher Pittenger, View ORCID ProfileAlex C. Kwan
doi: https://doi.org/10.1101/2022.11.03.515044
Sarah J. Jefferson
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Gregg
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ian Gregg
Mark Dibbs
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Dibbs
Clara Liao
2Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clara Liao
Hao Wu
2Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pasha A. Davoudian
2Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
3Medical Scientist Training Program, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pasha A. Davoudian
Jeffrey S. Sprouse
4Freedom Biosciences, Tiburon, CA 94920, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey S. Sprouse
Alexander M. Sherwood
5Usona Institute, Madison, WI 53711, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander M. Sherwood
Alfred P. Kaye
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
6VA National Center for PTSD Clinical Neuroscience Division, West Haven, CT 06516, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alfred P. Kaye
Christopher Pittenger
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
7Child Study Center, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher Pittenger
Alex C. Kwan
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
8Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, 06511, USA
9Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, 14853, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex C. Kwan
  • For correspondence: alex.kwan@cornell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

ABSTRACT

Serotonergic psychedelics are gaining increasing interest as potential therapeutics for a range of mental illnesses. Compounds with short-lived subjective effects may be clinically useful because dosing time would be reduced, which may improve patient access. One short-acting psychedelic is 5-MeO-DMT, which has been associated with improvement in depression and anxiety symptoms in early clinical studies. However relatively little is known about the behavioral effects and neural mechanisms of 5-MeO-DMT in animal models. Here we characterized the effects of 5-MeO-DMT on innate behaviors and dendritic architecture in mice. We showed that 5-MeO-DMT induces a dose-dependent increase in head-twitch response that is shorter in duration than that induced by psilocybin at all doses tested. 5-MeO-DMT also substantially suppresses social ultrasonic vocalizations produced during mating behavior. 5-MeO-DMT produces long-lasting increases in dendritic spine density in the mouse medial frontal cortex that are driven by an elevated rate of spine formation. However, unlike psilocybin, 5-MeO-DMT did not affect the size of dendritic spines. These data provide insights into the behavioral and neural consequences underlying the action of 5-MeO-DMT and highlight similarities and differences with those of psilocybin.

Competing Interest Statement

A.C.K. is a member of the Scientific Advisory Board of Empyrean Neuroscience and Freedom Biosciences. A.C.K. has consulted for Biohaven Pharmaceuticals. No-cost compounds were provided to A.C.K. for research by Usona Institute. C.P. has served as a consultant in the past year for Biohaven Pharmaceuticals, Teva Pharmaceuticals, and Brainsway Therapeutics and has performed research under contract with Biohaven and with Blackthorn Therapeutics, Ltd., on unrelated projects. C.P. and A.P.K have performed research under contract with Transcend Therapeutics on unrelated projects. C.P. and S.J.S. have a sponsored research agreement with Freedom Biosciences. The sponsor of this research was not involved in the analyses or writing of the manuscript. The duties had no influence on the content of this article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 03, 2022.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
Sarah J. Jefferson, Ian Gregg, Mark Dibbs, Clara Liao, Hao Wu, Pasha A. Davoudian, Jeffrey S. Sprouse, Alexander M. Sherwood, Alfred P. Kaye, Christopher Pittenger, Alex C. Kwan
bioRxiv 2022.11.03.515044; doi: https://doi.org/10.1101/2022.11.03.515044
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
Sarah J. Jefferson, Ian Gregg, Mark Dibbs, Clara Liao, Hao Wu, Pasha A. Davoudian, Jeffrey S. Sprouse, Alexander M. Sherwood, Alfred P. Kaye, Christopher Pittenger, Alex C. Kwan
bioRxiv 2022.11.03.515044; doi: https://doi.org/10.1101/2022.11.03.515044

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neuroscience
Subject Areas
All Articles
  • Animal Behavior and Cognition (4238)
  • Biochemistry (9159)
  • Bioengineering (6797)
  • Bioinformatics (24054)
  • Biophysics (12149)
  • Cancer Biology (9564)
  • Cell Biology (13819)
  • Clinical Trials (138)
  • Developmental Biology (7654)
  • Ecology (11733)
  • Epidemiology (2066)
  • Evolutionary Biology (15536)
  • Genetics (10665)
  • Genomics (14353)
  • Immunology (9504)
  • Microbiology (22887)
  • Molecular Biology (9120)
  • Neuroscience (49094)
  • Paleontology (357)
  • Pathology (1487)
  • Pharmacology and Toxicology (2579)
  • Physiology (3851)
  • Plant Biology (8349)
  • Scientific Communication and Education (1473)
  • Synthetic Biology (2300)
  • Systems Biology (6204)
  • Zoology (1302)